Acadia Pharmaceuticals Announces U.S. FDA Approval of DAYBUE ™ (trofinetide) for the Treatment of Rett Syndrome in Adult and Pediatric Patients Two Years of…

Source: Reuters: Health - Category: Consumer Health News Source Type: news